Advertisement

Revista de Oncología

, Volume 6, Issue 6, pp 362–372 | Cite as

Tratamiento quirúrgico de las metástasis pulmonares

  • Juan Lago Viguera
Artículo Especial
  • 44 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografía

  1. 1.
    Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43(Suppl):S15–25.CrossRefGoogle Scholar
  2. 2.
    Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from nongynecological malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358–63.CrossRefPubMedGoogle Scholar
  3. 3.
    Chu DZJ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecological malignancy: a prospective study of prognostic factors. Cancer 1989;63:364–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Jayne DG, Fook S, Loi S, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89: 1545–50.CrossRefPubMedGoogle Scholar
  5. 5.
    De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–47.PubMedGoogle Scholar
  6. 6.
    Lockich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continous infusion fluorouracil with conventional bolus schedule in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program Study. J Clin Oncol 1989;7:425–32.Google Scholar
  7. 7.
    Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905–14.CrossRefPubMedGoogle Scholar
  8. 8.
    Beaujard AC, Glehen O, Caillot JL, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000;88(11):2512–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Piso P, Bektas H, Werner X, et al. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 2001;27:286–90.CrossRefPubMedGoogle Scholar
  10. 10.
    Elias D, Dubé P, Blot F, et al. Peritoneal carcinomatosis treatment with curative intent: the Institute Gustave-Roussy experience. Eur J Surg Oncol 1997;23:317–21.CrossRefPubMedGoogle Scholar
  11. 11.
    Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138:26–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Gilly FN, Sayag AC, Carry PY, et al. Chimio-hyperthermie intra-peritoneale (CHIP) dans le traitament des carninoses peritoneales d'órigine digestive. Rapport d'une observation et données physiopathologiques. J Chir (París) 1990;127(2):95–8.Google Scholar
  13. 13.
    Pestieau SR, Sugarbaker PH, Treatment of primary colon cancer with peritoneal carcinomatosis. Comparison of concomitant vs delayed management. Dis Colon Rectum 2000;43(10):1341–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Witkamp AJ, De Bree E, Van Goethem AR, Zoetmulder FAN. Antitumour treatment. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treatment Reviews 2001;27:365–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Yonemura Y, Fujimura T, Fushida S, et al. Hypoerthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15(4):530–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbeck's Arch Surg 1999;384:576–87.CrossRefGoogle Scholar
  17. 17.
    Dubé P, Lasser PH, Elias D, Traitement de la carcinose peritoneale d'órigine colorectal. J Chir (Paris) 1997;134 (5–6):233–6.Google Scholar
  18. 18.
    Maughan TS, James RD, Kerr DJ, et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimen in metastatic colorectal cancer: a multicentre randomised trial. Lancet 2002;359:1555–63.CrossRefPubMedGoogle Scholar
  19. 19.
    Spratt JS, Adcock RA, Muskovin M, et al. Clinical de livery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:2563–5.Google Scholar
  20. 20.
    Elias D, El Otmany A, Bonnay M, et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncology 2002;63:346–52.CrossRefPubMedGoogle Scholar
  21. 21.
    Gomez Portilla A, Sugarbaker PH, Chang D, Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognosis features. World J Surg 1999;23:23–9.CrossRefGoogle Scholar
  22. 22.
    Schneebaum S, Arnold MW, Staubus A, Young DC, Dumond D, Martin EW Jr. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44–50.CrossRefPubMedGoogle Scholar
  23. 23.
    Elias D, Blot F, El Otmany A, et al. Curative Treatment of Peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Fujimura T, Yonemura Y, Fujita H, et al. Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. Int Surg 1999;84(1):60–6.PubMedGoogle Scholar
  25. 25.
    Cavaliere F, Perri P, Di Filippo F, et al. Treatment of peritoneal carcinomatosis with intent of cure. J Surg Oncol 2000;74:41–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Witkamp AJ, de Bree E, Kaag MM, Van Slooten GW, Van Coervorden F, Zoetmulder FAN, Extensive surgical cytoreduction and intra-operative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458–63.CrossRefPubMedGoogle Scholar
  27. 27.
    Sugarbaker PH, Schellinx MET, Chang D, Koslowe P, Von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585–92.CrossRefPubMedGoogle Scholar
  28. 28.
    Zoetmulder FAN, Verwaal V. Hyperthermic intrapoeritoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin [abstract]. ASCO Prog Proc 2002;21:147a.Google Scholar
  29. 29.
    Elias D, Dube P, Bonvalot S, et al. Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate postoperative intraperitoneal chemotherapy: Feasibility and preliminary results. Hepato-Gastroenterol 1999;46:360–9.Google Scholar

Copyright information

© FESEO 2004

Authors and Affiliations

  • Juan Lago Viguera
    • 1
  1. 1.Servicio de Cirugía TorácicaHospital Ramón y CajalMadridEspaña

Personalised recommendations